Paclitaxel treatment does not appear to affect the risk of epirubicin-related cardiotoxicity

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1017, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antenatal betamethasone does not appear to affect cardiovascular risk factors in adulthood

Reactions Weekly, Vol. 1, Iss. 1054, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Treatment with tyrosine kinase inhibitors does not appear to be associated with an increased risk of depression

Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Prolonged cetirizine treatment for atopic dermatitis does not appear to adversely affect behavioural, cognitive or psychomotor development

Inpharma, Vol. 1, Iss. 1356, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive Breast Cancer: A Phase II Study

By Sarid David

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 691-701

Adis International

Access to resources Recommend Favorite

Micellar paclitaxel does not appear to be effective in patients with multiple sclerosis

Inpharma, Vol. 1, Iss. 1328, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite